The mystery of sudden death: Mechanisms for risks

Epilepsy and Behavior

Volumn 12, Issue 1, 2008, Pages 3-24

  Lathers, Claire M ^a   Schraeder, Paul L ^b   Bungo, Michael W ^c  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Cardiac risk factors for sudden death; Epilepsy; Interventions; Stress; Sudden death; Sudden unexpected death in epilepsy

Indexed keywords

ALDOSTERONE ANTAGONIST; AMIODARONE; ANTIARRHYTHMIC AGENT; ANTICONVULSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBAMAZEPINE; CHLORPROMAZINE; CLONIDINE; DIAZEPAM; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLUOXETINE; GABAPENTIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LAMOTRIGINE; LORAZEPAM; NEUROLEPTIC AGENT; PHENOBARBITAL; PHENYTOIN; PROCAINAMIDE; PROPRANOLOL; PSYCHOTROPIC AGENT; QUINIDINE; ROFECOXIB; THIORIDAZINE; TIAGABINE; TIMOLOL; TOPIRAMATE; UNINDEXED DRUG; ZONISAMIDE;

4 AMINOBUTYRIC ACID RELEASE; AMYGDALOID NUCLEUS; ANTIARRHYTHMIC ACTIVITY; ANTICONVULSANT ACTIVITY; ANXIETY; ARRHYTHMOGENESIS; AUTONOMIC NERVOUS SYSTEM; BRUGADA SYNDROME; CARDIOPULMONARY HEMODYNAMICS; CARDIOVASCULAR DISEASE; COGNITIVE DEFECT; CONVULSION; DEPRESSION; DIABETES MELLITUS; DRUG DOSE INCREASE; DRUG MECHANISM; DRUG POTENTIATION; DYSLIPIDEMIA; EPILEPSY; EPILEPTIC DISCHARGE; EPILEPTOGENESIS; GENE MUTATION; GENERALIZED EPILEPSY; GENETIC PREDISPOSITION; GENETIC RISK; GLAUCOMA; HEART ARRHYTHMIA; HEART DISEASE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART RATE VARIABILITY; HEART RIGHT VENTRICLE DYSPLASIA; HUMAN; HYPOTHALAMUS; ISCHEMIC HEART DISEASE; LETHARGY; LONG QT SYNDROME; LUNG EDEMA; NONHUMAN; ORTHOSTATIC HYPOTENSION; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; RADIOFREQUENCY ABLATION; REVIEW; RISK FACTOR; SEDATION; SEIZURE; SIDE EFFECT; STRESS; SUDDEN DEATH; SUDDEN INFANT DEATH SYNDROME; SYMPATHETIC INNERVATION; TACHYCARDIA; TONIC CLONIC SEIZURE; WEIGHT GAIN;

DEATH, SUDDEN; EPILEPSY; HEART DISEASES; HUMANS; RISK;

EID: 37049036197     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2007.09.016     Document Type: Review

References (262)

1. Lathers C.M., Roberts J., and Kelliher G.J. Relationship between the effect of ouabain on arrhythmia and interspike intervals (ISI) of cardiac accelerator nerves. Pharmacologist 16 (1974) 201
2. Lathers C.M., Kelliher G.J., and Roberts J. Correlation of ouabain-induced arrhythmia and nonuniformity in cardiac accelerator nerves. Clin Res 22 (1974) 682A
3. Lathers C.M., Roberts J., and Kelliher G.J. Correlation of ouabain-induced arrhythmia and nonuniformity in the histamine-evoked discharge of cardiac sympathetic nerves. J Pharmacol Exp Ther 203 (1977) 467-479
4. Lathers C.M., Kelliher G.J., Roberts J., and Beasley A.B. Nonuniform cardiac sympathetic nerve discharge: mechanism for coronary occlusion and digitalis-induced arrhythmia. Circulation 57 (1978) 1058-1065
5. Lathers C.M., Lipka L.J., and Klions H.A. Digitalis glycosides: a discussion of the similarities and differences in actions and existing controversies. Rev Clin Basic Pharmacol 7 (1988) 1-108
6. Lathers C.M. Effect of timolol on postganglionic cardiac and preganglionic splanchnic sympathetic neural discharge associated with ouabain-induced arrhythmia. Eur J Pharmacol 64 (1980) 95-106
7. Lathers C.M., and Roberts J. Are the sympathetic neural effects of digoxin and quinidine involved in their action on cardiac rhythm?. J Cardiovasc Pharmacol 7 (1985) 350-360
8. Lathers C.M., Kelliher G.J., Roberts J., and Beasley A.B. Role of the adrenergic nervous system in arrhythmia produced by acute coronary artery occlusion. In: Lefer A., Kelliher G., and Rovetto M. (Eds). Pathophysiology and therapeutics of myocardial ischemia (1977), Spectrum, New York 123-147
9. Spivey W.H., and Lathers C.M. Effect of timolol on the sympathetic nervous system in coronary occlusion in cats. Ann Emerg Med 134 (1985) 939-944
10. Lathers C.M. Lack of effect of methylprednisolone on cardiac neural discharge associated with coronary occlusion-induced arrhythmia and death. Eur J Pharmacol 85 (1982) 233-238
11. Evans D.E., and Gillis R.A. Reflex mechanisms involved in cardiac arrhythmias induced by hypothalamic stimulation. Am J Physiol 234 (1978) H199-H209
12. Schraeder P.L., and Lathers C.M. Autonomic dysfunction in epilepsy: I. A proposed animal model for unexplained sudden death in epilepsy. Clin Res 28 (1980) 618A
13. Carnel S.B., Schraeder P.L., and Lathers C.M. Autonomic dysfunction in epilepsy: II. Cardiovascular changes associated with pentylenetetrazol-induced seizures. Clin Res 28 (1980) 609A
14. Lathers C.M., and Schraeder P.L. Autonomic dysfunction in epilepsy: III. Characterization of autonomic cardiac neural discharge associated with pentylenetetrazol-induced seizures. Clin Res 28 (1980) 615A
15. Lathers C.M., and Schraeder P.L. Autonomic dysfunction in epilepsy: characterization of autonomic cardiac neural discharge associated with pentylenetetrazol-induced epileptogenic activity. Epilepsia 23 (1982) 633-648
16. Schraeder P.L., and Lathers C.M. Cardiac neural discharge and epileptogenic activity in the cat: an animal model for unexplained sudden death. Life Sci 32 (1983) 1371-1382
17. Han J., and Moe G.K. Nonuniform recovery of excitability in ventricular muscle. Circ Res 14 (1964) 44-60
18. Lathers C.M., Schraeder P.L., and Carnel S.B. Neural mechanisms in cardiac arrhythmias associated with epileptogenic activity: the effect of phenobarbital in the cat. Life Sci 34 (1984) 1919-1936
19. Carnel S.B., Schraeder P.L., and Lathers C.M. The effect of phenobarbital pretreatment on cardiac neural discharge and pentylenetetrazol-induced epileptogenic activity. Pharmacol 20 (1985) 225-240
20. Lathers C.M., and Schraeder P.L. Arrhythmias associated with epileptogenic activity elicited by penicillin. In: Lathers C.M., and Schraeder P.L. (Eds). Epilepsy and sudden death (1990), Dekker, New York 157-167
21. Lathers C.M., Schraeder P.L., and Tumer N. The effect of phenobarbital on autonomic function and epileptogenic activity induced by the hippocampal injection of penicillin in cats. J Clin Pharmacol 33 (1993) 837-844
22. Lathers C.M., Schraeder P.L., and Weiner F.L. Synchronization of cardiac autonomic neural discharge with epileptogenic activity: the lock step phenomenon. Electroencephalogr Clin Neurophysiol 67 (1987) 247-259
23. Stauffer A.Z., Dodd-o J., and Lathers C.M. The relationship of the lock step phenomenon and precipitous changes in mean arterial blood pressure. Electroencephalogr Clin Neurophysiol 72 (1989) 340-345
24. Lathers C.M., Jim K.F., Spivey W.H., Kahn C., Dolce K., and Matthews W.D. Antiepileptic activity of beta-blocking agents. In: Lathers C.M., and Schraeder P.L. (Eds). Epilepsy and sudden death (1990), Dekker, New York 485-505
25. Lathers C.M., Stauffer A.Z., Turner N., Kraras C.M., and Goldman B.D. Anticonvulsant and antiarrhythmic actions of the beta blocking agent timolol. Epilepsy Res 4 (1989) 42-54
26. Mameli P., Mameli O., Tolu E., et al. Neurogenic myocardial arrhythmias in experimental focal epilepsy. Epilepsia 29 (1988) 74-82
27. 2: explanation for epileptogenic activity and dysfunction in autonomic cardiac neural discharge leading to arrhythmias. Med Hypoth 15 (1984) 15-30
28. Kraras C.M., Tumer N., and Lathers C.M. The role of neuropeptides in the production of epileptogenic activity and autonomic dysfunction: origin of arrhythmia and sudden death in the epileptic patient?. Med Hypoth 23 (1987) 19-31
29. Lathers C.M., Tumer N., and Kraras C.M. Cardiovascular and epileptogenic effects of pentylenetetrazol administered intracerebroventricularly in cats. Epilepsia 26 (1985) 520
30. Lathers C.M., Tumer N., and Kraras C.M. The effect of intracerebroventricular (ICV) d-ala2-methionine enkephalinamide (DAME) and naloxone on cardiovascular parameters in the cat. Life Sci 43 (1988) 2287-2298
31. Lathers C.M. Role of neuropeptides in the production of epileptogenic activity and arrhythmias. In: Lathers C.M., and Schraeder P.L. (Eds). Epilepsy and sudden death (1990), Dekker, New York 309-327
32. Schwartz R.D., and Lathers C.M. GABA neurotransmission, epileptogenic activity, and cardiac arrhythmias. In: Lathers C.M., and Schraeder P.L. (Eds). Epilepsy and sudden death (1990), Dekker, New York 293-307
33. Vindrola O., Asai M., Zubieta M., Talavera E., Rodriguez E., and Linares G. Pentylenetetrazol kindling produces a long-lasting elevation of IR-Met-enkephalin but not IR-Leu-enkephalin in rat brain. Brain Res 297 (1984) 121-125
34. Brennan M.J., Cantrill R.C., and Wylie B.A. Modulation of synaptosomal GABA release by enkephalin. Life Sci 27 (1980) 1097-1101
35. Snead III O.C., and Bearden L.J. Anticonvulsants specific for petit mal antagonize epileptogenic effect of leucine enkephalin. Science 210 (1980) 1031-1033
36. Yukimura J., Stock G., Stumpf H., Unger T., and Ganten D. Effects of (d-Ala2)-methionine-enkephalin in blood pressure, heart rate, and baroreceptor reflex sensitivity in conscious cats. Hypertension 3 (1981) 528-533
37. Dhir A., and Kulkarni S.K. Rofecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor potentiates the anticonvulsant activity of tiagabine against pentylenetetrazol-induced convulsions in mice. Inflammopharmacology 14 (2006) 222-225
38. 123I]metaiodobenzylguanidine-SPECT. Brain 124 (2001) 372-382
39. Ieda M., Kanazawa H., Kimura K., et al. Sema3a maintains normal heart rhythm through sympathetic innervation patterning. Nat Med 13 (2007) 604-612
40. Hilz M.J., Devinsky O., Doyle W., Mauerer A., and Dutsch M. Decrease of sympathetic cardiovascular modulation after temporal lobe epilepsy surgery. Brain 125 Pt. 5 (2002) 985-995
41. Goodman J.H., Homan R.W., and Crawford I.L. Kindled seizures activate both branches of the autonomic nervous system. Epilepsy Res 34 (1999) 169-176
42. Goodman J.H., Homan R.W., and Crawford I.L. Kindled seizures elevate blood pressure and induce cardiac arrhythmias. Epilepsia 31 (1990) 489-495
43. Goodman J.H., Berger R.E., and Tcheng T.K. Preemptive low-frequency stimulation decreases the incidence of amygdala-kindled seizures. Epilepsia 46 (2005) 1-7
44. Gary-Bobo E.G., and Bonvalette M. Commissural projection to the amygdala through the fimbria fornix system in the cat. Exp Brain Res 27 (1977) 61-70
45. Simon R.P., Bayne L.L., Tranbaugh R.F., and Lewis F.R. Elevated pulmonary flow and protein content during status epilepticus in sheep. J Appl Physiol 52 (1982) 91-95
46. Johnston S.C., Horn J.K., Valente J., and Simon R.P. The role of hypoventilation in a sheep model of epileptic sudden death. Ann Neurol 37 (1995) 531-537
47. Johnston S.C., Siedenberg R., Min J.K., Jerome E.H., and Laxer K.D. Central apnea and acute cardiac ischemia in a sheep model of epileptic sudden death. Ann Neurol 42 (1997) 588-594
48. Tupal S., and Faingold C.L. Evidence supporting a role of serotonin in modulation of sudden death induced by seizures in DBA/2 mice. Epilepsia 47 (2006) 21-26
49. Tupal S., and Faingold C.L. Respiratory arrest mechanisms, modulated in part by serotonin, may cause SUDEP. Epilepsia 47 (2006) 21-26
50. Jay G.W., and Leestma J.E. Sudden death in epilepsy. CTA Neurol Scand 63 Suppl. 82 (1981) 1-66
51. Kiok M.C., Terrence C.F., Fromm G.H., and Lavine S. Sinus arrest in epilepsy. Neurology 36 (1986) 115-116
52. Lathers C.M., and Schraeder P.L. Synchronized cardiac neural discharge and epileptogenic activity, the lock step phenomenon: lack of correlation with cardiac arrhythmias. In: Lathers C.M., and Schraeder P.L. (Eds). Epilepsy and sudden death (1990), Dekker, New York 187-198
53. Stauffer, Dodd-o, and Lathers C.M. Relationship of the lock step phenomenon and precipitous changes in blood pressure. In: Lathers C.M., and Schraeder P.L. (Eds). Epilepsy and sudden death (1990), Dekker, New York 221-238
54. O'Rouke K., and Lathers C.M. Interspike interval histogram characterization of synchronized cardiac sympathetic neural discharge and epileptogenic activity in the electrocorticogram of the cat. In: Lathers C.M., and Schraeder P.L. (Eds). Epilepsy and sudden death (1990), Dekker, New York 239-260
55. Dodd-o J.M., and Lathers C.M. A characterization of the lock step phenomenon in phenobarbital-pretreated cats. In: Lathers C.M., and Schraeder P.L. (Eds). Epilepsy and sudden death (1990), Dekker, New York 199-220
56. Leestma J.E., Kalelkar M.B., Teas S.S., Jay G.W., and Hughes J.R. Sudden unexpected death associated with seizures: analysis of 66 cases. Epilepsy 25 (1984) 84-88
57. Allen W.F. An experimentally produced premature systolic arrhythmia (pulsus bigeminus) in rabbits. Am J Physiol 98 (1931) 344-351
58. Hahn F. Analeptics. Pharmacol Rev 12 (1960) 447-530
59. Gebber G.L., and Barman S.M. Sympathetic-related activity of brain stem neurons in baroreceptor-denervated cats. Am J Physiol 240 (1981) R348-R355
60. Birks R.I. Regulation by patterned preganglionic neural activity of transmitter stores in sympathetic ganglion. J Physiol 280 (1978) 559-572
61. Birks R.I., Laskey W., and Polosa C. The effect of burst patterning of preganglionic input on the efficacy of transmission at the cat stellate ganglion. J Physiol 318 (1981) 531-539
62. Winfree A.T. When time breaks down: the three-dimensional dynamics of electrochemical waves and cardiac arrhythmias (1987), Princeton Univ. Press, Princeton, NJ
63. Randall W.C., Thomas J.X., Euler D.E., and Rosanski G.L. Cardiac dysrhythmias associated with autonomic nervous system imbalance in the conscious dog. In: Schwartz P.J., Brown A.M., Malliani A., and Zanchetti A. (Eds). Perspectives in cardiovascular research: Neural mechanisms in cardiac arrhythmias vol. 2 (1978), Raven Press, New York 123-138
64. Guyton A.C. Arrhythmic excitation of the heart. In: Guyton A.C. (Ed). Textbook of medical physiology (1981), Saunders, Philadelphia 165-175
65. Gleick J. Chaos: making a new science (1987), Viking, New York
66. Goldberger A.L., Bhargava V., and West B.J. Nonlinear dynamics of the heart beat. Physica D 17 (1985) 207-214
67. Van Buren J.M. Some autonomic concomitant of ictal automatism. Brain 81 (1958) 505-528
68. Lathers C.M., Levin R.M., and Spivey W.H. Regional distribution of myocardial receptors. Eur J Pharmacol 130 (1986) 111-117
69. Lathers C.M., Spivey W.H., Suter L.E., Lerner J.P., Turner N., and Levin R.M. The effect of acute and chronic administration of timolol on cardiac sympathetic neural discharge, arrhythmias, and beta receptor density associated with coronary occlusion in the cat. Life Sci 39 (1986) 2121-2141
70. Lathers C.M., Spivey W.H., Levin R.M., and Tumer N. The effect of dilevalol on cardiac autonomic neural discharge, plasma catecholamines, and myocardial beta receptor density associated with coronary occlusion. J Clin Pharmacol 30 (1990) 241-253
71. Lathers C.M., and Spivey W.H. The effect of timolol, metoprolol, and practolol on postganglionic cardiac neural discharge associated with acute coronary occlusion-induced arrhythmia. J Clin Pharmacol 27 (1987) 582-592
72. Lathers C.M., Spivey W.H., and Tumer N. The effect of timolol given five minutes post coronary occlusion on plasma catecholamines. J Clin Pharmacol 28 (1988) 289-299
73. Lathers C.M., Spivey W.H., and Levin R.M. The effect of chronic timolol in an animal model for myocardial infarction. J Clin Pharmacol 28 (1988) 736-745
74. Salata J.J., and Jalife J. "Fade" of hyperpolarizing response to vagal stimulation at the sinoatrial and atrioventricular nodes of the rabbit heart. Circ Res 56 (1985) 718-727
75. Saper C.B., Loewy A.D., Swanson L.W., and Cowan W.M. Direct hypothalamo autonomic connections. Brain Res 117 (1976) 305-312
76. Willis W.L., and Grossman R.G. Medical neurobiology (1981), C.V. Mosby, St. Louis p. 405
77. Natelson B.H. Neurocardiolology: An interdisciplinary area for the 80's. Arch Neurol 42 (1985) 178-184
78. Korner PI. Central nervous control of autonomic cardiovascular function. In: Berne RM, Sperelaskis N, Geiger SR, editors. Handbook of physiology: the cardiovascular system. Vol. 1. Am Physiol Soc, Bethesda, MD: 1979. p. 691-739.
79. Papez J.W. A proposed mechanism of emotion. Arch Neurol Psychiatry 38 (1937) 725-743
80. Wall P.D., and Davis G.D. Three cerebral cortical systems affecting autonomic function. J Neurophysiol 14 (1951) 507-517
81. Landau W.M. Autonomic responses mediated via the corticospinal tract. J Neurophysiol 16 (1953) 299-311
82. Breusch S.R. Anatomy of the human hypothalamus. In: Givens J.R. (Ed). The hypothalamus (1984), Year Book Medical, Chicago 13
83. Chapman W.P., Livingston K.E., and Papper J.L. Effect upon blood pressure of electrical stimulation of tips of temporal lobes in man. J Neurophysiol 13 (1950) 65-71
84. Hoff E.C., and Green H.G. Cardiovascular reactions induced by electrical stimulation of the cerebral cortex. Am J Physiol 17 (1936) 411-422
85. Delgado J.M.R. Circulating effects of cortical stimulation. Physiol Rev 40 (1960) 146-171
86. Kaada B.R., Pribram K.H., and Epstein J.A. Respiratory and vascular responses in monkeys from temporal lobe pole, insula, orbital surface and cingulate gyrus. J Neurophysiol 12 (1949) 347-356
87. Freytag J.R., and Ingraham F.D. 295 medical autopsies in epileptics. Arch Pathol 78 (1964) 274-286
88. Kiloh L.G., McComas A.J., and Osselton J.W. The neural basis of the EEG. In: Kiloh L.G., McComas A.J., and Osselton J.W. (Eds). Clinical encephalography (1972), Butterworth, London 21-34
89. Kiloh L.G., McComas A.J., and Osselton J.W. Normal findings. In: Kiloh L.G., McComas A.J., and Osselton J.W. (Eds). Clinical electroencephalography (1972), Butterworth, London 52-70
90. Kiloh L.G., McComas A.J., and Osselton J.W. The neural basis of the EEG. In: Kiloh L.G., McComas A.J., and Osselton J.W. (Eds). Clinical electroencephalography (1972), Butterworth, London 21-34
91. Baser E. Abstract methods of general systems analysis. In: Basar E. (Ed). Biophysical and physiological systems analysis (1976), Addison-Wesley, Reading, MA 23-47
92. Barman S.M., and Gebber G.L. Sympathetic nerve rhythm of brain stem origin. Am J Physiol 239 (1980) R42-R47
93. Barman S.M., and Gebber G.L. Brain stem neuronal types with activity patterns related to sympathetic nerve discharge. Am J Physiol 242 Regul Int Comp Physiol 11 (1981) R335-R347
94. Barman S.M., and Gebber G.L. Hypothalamic neurons with activity patterns related to sympathetic nerve discharge. Am J Physiol 242 (1982) R34-R43
95. Meldrum B.S., and Brierley J.B. Prolonged epileptic seizures in primates. Arch Neurol 28 (1973) 10-17
96. Meldrum B.S., and Horton R.W. Physiology of status epilepticus in primates. Arch Neurol 28 (1973) 1-9
97. Wasterlain C.G. Mortality and morbidity from serial studies: an experimental study. Epilepsia 15 (1974) 155-176
98. Leestma J.E., Walczak T., Hughes J.R., Kalelkar M.B., and Teas S.S. A prospective study on sudden unexpected death in epilepsy. Ann Neurol 26 (1989) 195-203
99. In: Lathers C.M., and Schraeder P.L. (Eds). Epilepsy and Sudden Death (1990), Marcel Dekker, New York
100. Davis G.G., and McGwin Jr. G. Comparison of heart mass in seizure patients dying of sudden unexplained death in epilepsy to sudden death due to some other cause. Am J Forens Med Pathol 25 (2004) 23-28
101. Leestma J.E., Annegers J.F., Brodie M.J., et al. Sudden unexplained death in epilepsy: observations from a large clinical trial. Epilepsia 38 (1997) 47-55
102. Walczak T.S., Leppik I.E., D'Amelio M., et al. Incidence and risk factors in sudden unexpected death in epilepsy: a prospective cohort study. Neurology 27 (2001) 519-525
103. Moran N.F., Poole K., Bell G., et al. Epilepsy in the United Kingdom: seizure frequency and severity, anti-epileptic drug utilization and impact on life in 1652 people with epilepsy. Seizure 3 (2004) 425-433
104. Rugg-Gunn F.J., Simister R.J., Squirrell M., Holdright D.R., and Duncan J.S. Cardiac arrhythmias in focal epilepsy: a prospective long-term study. Lancet 364 (2004) 2212-2219
105. Earnest M.P., Thomas G.E., Eden R.A., and Hossack K.F. The sudden unexplained death syndrome in epilepsy: demographic, clinical, and postmortem features. Epilepsia 33 (1992) 310-316
106. McKee J.R., and Bodfish J.W. Sudden unexpected death in epilepsy in adults with mental retardation. Am J Ment Retard 105 (2000) 229-235
107. Langan Y. Sudden unexpected death in epilepsy: risk factors and case control studies. Seizure 9 (2000) 179-183
108. Langan Y. Sudden unexpected death in epilepsy: a series of witnessed deaths. J Neurol Neurosurg Psychiatry 68 (2000) 211-213
109. Ficker DM. Sudden unexplained d., and injury in e. Epilepsia 41 Suppl. 2 (2000) S7-S12
110. Lhatoo S.D., Langan Y., and Sander J.W. Sudden unexpected death in epilepsy. Postgrad Med J 75 (1999) 706-709
111. Ficker D.M., So E., Sehn W.K., et al. Population-based study of the incidence of sudden unexplained death in epilepsy. Neurology 51 (1998) 1270-1274
112. Langan Y., Nolan N., and Hutchinson M. The incidence of sudden unexpected death in epilepsy (SUDEP) in South Dublin and Wicklow. Seizure 7 (1998) 355-359
113. George J.R., and Davis G.G. Comparison of anti-epileptic drug levels in different cases of sudden death. J Forens Sci 43 (1998) 498-603
114. Nashef L., Garner S., Sander J.W., Fish D.R., and Shorvon S.D. Circumstances of death in sudden death in epilepsy interview of bereaved relatives. J Neurol Neurosurg Psychiatry 64 (1998) 349-352
115. Coyle H.P., Baker-Brian N., and Brown S.W. Coroners' autopsy reporting of sudden unexplained death in epilepsy (SUDEP) in the UK. Seizure 3 (1994) 247-254
116. Harvey A.S., Nolan T., and Carlin J.B. Community-based study of mortality in children with epilepsy. Epilepsia 34 (1993) 597-603
117. Langan Y., Nashef L., and Sander J.W. Certification of deaths attributable to epilepsy. J Neurol Neurosurg Psychiatry 73 (2002) 751-752
118. Langan Y., Nashef L., and Sander J.W. Sudden unexpected death in epilepsy: a series of witnessed deaths. J Neurol Neurosurg Psychiatry 68 (2000) 211-213
119. Tellez-Zenteno J.F., Ronquillo L.H., and Wiebe S. Sudden unexpected death in epilepsy: evidence-based analysis of incidence and risk factors. Epilepsy Res 65 (2005) 101-115
120. Bell G.S., and Sander J.W. Sudden unexpected death in epilepsy: risk factors, possible mechanisms and prevention: a reappraisal. Acta Neurol Taiwan 15 (2006) 72-83
121. Lathers C.M., and Schraeder P.L. Stress and sudden death. Epilepsy Behav 9 (2006) 236-242
122. Schraeder P.L., Delin K., McClelland R.L., and So E.L. Coroner and medical examiner documentation of sudden unexplained deaths in epilepsy. Epilepsy Res 68 (2006) 137-143
123. Leiter JC, Böhm I. Mechanisms of pathogenesis in the sudden infant death syndrome. Respir Physiol Neurobiol 2007 Jun 8 [Epub ahead of print].
124. Franco Folino A. Cerebral autoregulation and syncope. Prog Cardiovasc Dis 50 (2007) 49-80
125. Beauregard L.A., Fabiszewski R., Black C.H., et al. Combined ambulatory electroencephalographic and electrocardiographic recordings for evaluation of syncope. Am J Cardiol 68 (1991) 1067-1072
126. Schraeder P.L., Lathers C.M., and Charles J.B. The spectrum of syncope. J Clin Pharmacol 34 (1994) 454-459
127. Goldenberg I., Moss A.J., and Zareba W. Sudden cardiac death without structural heart disease: update on the long QT and Brugada syndromes. Curr Cardiol Rep 7 (2005) 349-356
128. Vohra J. The long QT syndrome. Heart Lung Circ 16 Suppl. 3 (2007) S5-S12
129. Bezzina C.R., Shimizu W., Yang P., et al. Common sodium channel promoter haplotype Asian subjects underlies variability in cardiac conduction. Circulation 24 113 (2006) 338-344
130. + channel-linked long-QT syndrome. Circ Res 78 (1996) 916-924
131. Leung H., Kwan P., and Elger C.E. Finding the missing link between ictal bradyarrhythmia, ictal asystole, and sudden unexpected death in epilepsy. Epilepsy Behav 9 (2006) 19-30
132. P-Codrea Tigeran S., Dalager-Pedersen S., Baandrup U., Dam M., and Vesterby-Charles A. Sudden unexpected death in epilepsy: is death by seizures a cardiac disease?. Am J Forens Med Pathol 26 (2005) 99-105
133. Natelson B.H., Suarez R.V., Terrence C.F., and Turizo R. Patients with epilepsy who die suddenly have cardiac disease. Arch Neurol 55 (1998) 857-860
134. Meregalli P.G., Wilde A.A., and Tan H.L. Pathophysiological mechnisms of Brugada syndrome: depolarization disorder, repolarization disorder, or more?. Cardiovasc Res 67 (2005) 367-378
135. Kothari S.S. When epilepsy masquerades as heart disease. Postgrad Med 88 (1990) 167-171
136. Katz R.I., Tiger M., and Harner R.N. Epileptic cardiac arrhythmias: sinoatrial arrest in two patients. A potential cause of sudden death in epilepsy?. Epilepsia 24 (1983) 248
137. Ficker D.M., Cascino G.D., and Clements I.P. Cardiac asystole masquerading as temporal lobe epilepsy. Mayo Clin Proc 73 (1998) 784-786
138. Narang M., Dua T., Gomber S., and Mahajan V. Cardiac syncope from occult transposition masquerading as convulsive epilepsy. Eur J Paediatr Neurol 9 (2005) 361-362
139. Woodley D., Chambers W., Starke H., Dzindzio B., and Forker A.D. Intermittent complete atrioventricular block masquerading as epilepsy in the mitral valve prolapse syndrome. Chest 72 (1977) 369-372
140. Aronow W.S., Herzig A.H., Etienne F., D'Alba P., and Ronquillo J. 41-month follow-up of risk factors correlated with new coronary events in 708 elderly patients. J Am Geriatr Soc 37 (1989) 501-506
141. Lecomte D., Fornes P., and Nicolas G. Stressful events as a trigger of sudden death: a study of 43 medico-legal autopsy cases. Forens Sci Int 79 (1996) 1-10
142. Fornes P., Ratel S., and Lecomte D. Pathology of arrhythmogenic right ventricular cardiomyopathy/dysplasia: an autopsy study of 20 forensic cases. J Forens Sci 43 (1998) 777-783
143. Jouven X., Desnos M., Guerot C., and Ducimetiere P. Predicting sudden death in the population: the Paris Prospective Study I. Circulation 99 (1999) 1978-1983
144. Varnava A.M., Elliott P.M., Baboonian C., Davison F., Davies M.J., and McKenna W.J. Hypertrophic cardiomyopathy: histopathological features of sudden death in cardiac troponin T disease. Circulation 104 (2001) 1380-1384
145. Ackerman M.J., Splawski I., Makielski J.C., et al. Spectrum and prevalence of cardiac sodium channel variants among black, white, Asians, and Hispanic individuals: implications for arrhythmogenic susceptibility and Brugada/long QT syndrome genetic testing. Heart Rhythm 1 (2004) 608-609
146. Ali I.A., Iliescu C.A., and Smalling R.W. Brugada syndrome in a black man with seizures and incontinence. Tex Heart Inst J 33 (2006) 273-274
147. Shimizu W., and Antzelevitch C. Cellular basis for long QT, transmural dispersion of repolarization, and torsade de pointes in the long QT syndrome. J Electrocardiol 32 Suppl. (1999) 177-184
148. Crispell K.A. Familial cardiomyopathies: significant causes of heart failure. Curr Cardiol Rep 5 (2003) 187-192
149. Janse M.J. A brief history of sudden cardiac death and its therapy. Pharmacol Ther 100 (2003) 89-99
150. Ko Y.L., Teng M.S., Tang T.K., et al. Genetic heterogeneity for familial hypertrophic cardiomyopathy in Chinese: analysis of six Chinese kindreds. Chin Med J 111 (1998) 416-421
151. Cuda G., Lamberti A., Perrotti N., Perticone F., and Mattioli P.L. Familial hypertrophic cardiomyopathy: molecular basis and genotype-phenotype correlations. Rev Port Cardiol 17 Suppl. 2 (1998) II21-II31
152. Pellnitz C., Geier C., Perrot A., Dietz R., Osterziel K.J., and Haverkamp W. Sudden cardiac death in familial hypertrophic cardiomyopathy. Identification of high-risk patients. Dtsch Med Wochenschr 30 (2005) 1150-1154
153. Piano M.R. Familial hypertrophic cardiomyopathy. J Cardiovasc Nurs 13 (1999) 46-58
154. Domenighetti A.A., Boixel C., Cefai D., Abriel H., and Pedrazzini T. Chronic angiotensin II stimulation in the heart produces an acquired long QT syndrome associated with IK1 potassium current downregulation. J Mol Cell Cardiol 42 (2007) 63-70
155. Bingham A.J., Ooi L., Kozera L., White E., and Wood I.C. The repressor element 1-silencing transcription factor regulates heart-specific gene expression using muliple chromatin-modifying complexes. Mol Cell Biol 27 (2007) 4082-4092
156. Sarubbi B., D'Alto M., Vergara P., et al. Electrophysiological evaluation of asymptomatic ventricular pre-excitation in children and adolescents. Int J Cardiol 98 (2005) 207-214
157. Wichter T., Paul T.M., Eckardt L., et al. Arrhythmogenic right ventricular cardiomyopathy: antiarrhythmic drugs, catheter ablation, or ICD?. Herz 30 (2005) 91-101
158. Basso C., Corrado D., and Thiene G. Cardiovascular causes of sudden death in young individuals including athletes. Cardiol Rev 7 (1999) 127-135
159. Osswald S.S., Gaffney F.A., Kruyer W.B., Pickard J.S., and Jackson W.G. Military aviators with mitral valve prolapse: long-term followup and aeromedical endpoints. Aviat Space Environ Med 78 (2007) 845-851
160. Gray M.A., Taggart P., Sutton P.M., et al. A cortical potential reflecting cardiac function. Proc Natl Acad Sci USA. 104 (2007) 6818-6823
161. Stopper M., Joska T., Burg M.M., et al. Electrophysiologic characteristics of anger-triggered arrhythmias. Heart Rhythm 4 (2006) 268-273
162. Nagele H., Hashagen S., Azizi M., Behrens S., and Castel M.A. Analysis of terminal arrhythmias stored in the memory of pacemakers from patients dying suddenly. Europace 9 (2007) 380-384
163. Quint S.R., Messenheimer J.A., and Tennison M.B. Power spectral analysis: a procedure for assessing autonomic activity related to risk factors for sudden and unexplained death in epilepsy. In: Lathers C.M., and Schraeder P.L. (Eds). Epilepsy and sudden death (1990), Dekker, New York 261-291
164. Novak V., Reeves A.L., Novak P., Low P.A., and Sharbrough F.W. Time-frequency mapping of R-R interval during complex partial seizures of temporal lobe origin. J Auton Nerv Syst 24 (1999) 195-202
165. Everengul H., Tanriverdi H., Dursunoglu D., et al. Time frequency domain analyses of heart rate variability in patients with epilepsy. Epilepsy Res 63 (2005) 131-139
166. Persson H., Kumlien E., Ericson M., and Tomson T. Circadian variation in heart-rate variability in localization-related epilepsy. Epilepsia 48 (2007) 917-922
167. Sarkozy A., and Brugada P. Sudden cardiac death: what is inside our genes?. Can J Cardiol 21 (2005) 1099-1110
168. Salama G., and London B. Mouse models of long QT syndrome. J Physiol 578 Pt. 1 (2007) 43-53
169. Bingham A.J., Ooi L., and Wood I.C. Multiple chromatin modifications important for gene expression changes in cardiac hypertrophy. Biochem Soc Trans 34 Pt. 6 (2006) 1138-1140
170. Williams L., and Frenneaux M. Syncope in hypertrophic cardiomyopathy: mechanisms and consequences for treatment. Europace 9 (2007) 817-822
171. Grubb B.P., Gerard G., Wolfe D.A., et al. Syncope and seizures of psychogenic origin: identification with head-upright tilt table testing. Clin Cardiol 15 (1992) 839-842
172. Sheldon R.S., Sheldon A.G., Serletis A., et al. for the Investigators of the Prevention of Syncope Study. Worsening of symptoms before presentation with vasovagal syncope. J Cardiovasc Electrophysiol 18 (2007) 954-959
173. Franco F.A. Cerebral autoregulation and syncope. Prog Cardiovasc Dis 50 (2007) 49-80
174. Jain V. Clinical perspective of obstructive sleep apnea-induced cardiovascular complications. Antioxid Redox Signal 9 (2007) 701-710
175. Malow B.A., Levy K., Maturen K., and Bowes R. Obstructive sleep apnea is common in medically refractory epilepsy patients. Neurology 55 (2000) 1002-1007
176. Matschke J., and Laas R. Central alveolar hypoventilation syndrome causes SUD. Am J Forens Med Pathol 28 (2007) 141-144
177. Penfield W., and Jasper H. Summary of clinical analysis and seizure patterns. Epilepsy and the functional anatomy of human brain (1954), Little, Brown, Boston 830-831
178. Bobo E.G., and Bonvallet M. Amygdala and masseteric reflex: I. Facilitation, inhibition and diphasic modifications of the reflex, induced by localized amygdaloid stimulation. Electroencephalogr Clin Neurophysiol 39 (1975) 329-339
179. Coulter D.L. Partial seizures with apnea and bradycardia. Arch Neurol 41 (1984) 173-174
180. Terrence C.E., Rao G.R., and Pepper J.A. Neurogenic pulmonary edema in unexpected, unexplained death in epileptic patients. Neurology 25 (1981) 594-595
181. Schraeder P.L. Adult respiratory distress syndrome (ARDS) associated with nonconvulsive status epilepticus. Epilepsia 28 (1987) 605
182. Nashef L., Hindocha N., and Makoff A. Risk factors in sudden death in epilespy (SUDEP): the quest for mechanisms. Epilepsia 48 (2007) 859-871
183. Fenwick P. The behavioral treatment of epilepsy generation and inhibition of seizures. Neurol Clin 12 (1994) 175-202
184. Schraeder P.L., Pontzer R., and Engle T.R. A case of being scared to death. Arch Intern Med 143 (1983) 1793-1794
185. Monte C.P., Arends J.B., Tan I.Y., Aldenkamp A.P., Limburg M., and de Krom M.C. Sudden unexpected death in epilepsy patients: risk factors. A systematic review. Seizure 16 (2007) 1-7
186. Nilsson L., Bergman U., Diwan V., Farahmand B.Y., Persson P.G., and Tomson T. Antiepileptic drug therapy and its management in sudden unexpected death in epilepsy: a case-control study. Epilepsia 42 (2001) 667-673
187. Walczak T.S., Leppik I.E., D'Amelio M., et al. Incidence and risk factors in sudden unexpected death in epilepsy: a prospective cohort study. Neurology 56 (2001) 519-525
188. Opeskin K., and Berkovic S.F. Risk factors for sudden unexpected death in epilepsy: a controlled prospective study based on coroners cases. Seizure 12 (2003) 456-464
189. Vlooswijk M.C., Majoie H.J., DeKrom M.C., Tan I.Y., and Aldenkamp A.P. SUDEP in The Netherlands: a retrospective study in a tertiary referral center. Seizure 16 (2007) 153-159
190. Michelsen J.W., and Meyer J.M. Cardiovascular effects of antipsychotics. Expert Rev Neurother 7 (2007) 829-839
191. Lipka L.J., Lathers C.M., and Roberts J. Does chlorpromazine produce cardiac arrhythmia via the central nervous system?. J Clin Pharmacol 28 (1988) 968-983
192. Lathers C.M., and Lipka L.J. Chlorpromazine: cardiac arrhythmogenicity in the cat. Life Sci 38 (1986) 521-538
193. Lathers C.M., and Lipka L.J. Cardiac arrhythmia, sudden death, and psychoactive agents. J Clin Pharmacol 27 (1987) 1-14
194. Lipka L.J., and Lathers C.M. Psychoactive agents, seizure production, and sudden death in epilepsy. J Clin Pharmacol 27 (1987) 169-183
195. Lathers C.M., Flax R.F., and Lipka L.J. The effect of C1 spinal cord transection or bilateral adrenal vein ligation on thioridazine-induced arrhythmia and death in the cat. J Clin Pharmacol 26 (1986) 515-523
196. Reingardiene D., and Vilcinskaite J. QTc-prolonging drugs and the risk of sudden death. Medicina (Kaunas) 43 (2007) 347-353
197. Walczak T. Do antiepileptic drugs play a role in sudden unexpected death in epilepsy?. Drug Saf 26 (2003) 673-683
198. Lathers C.M., and Schraeder P.L. Clinical pharmacology: drugs as a benefit and/or risk in sudden unexpected death in epilepsy?. J Clin Pharmacol 42 (2002) 123-136
199. Lathers C.M., Schraeder P.L., and Claycamp H.G. Clinical pharmacology of topirimate vs. lamotrigine vs phenobarbital: comparision of efficacy and side effects using odds ratios. J Clin Pharmacol 43 (2003) 491-503
200. 2+ release channel (ryanodine receptor) mutant associated with ventricular tachycardia and sudden death. Circ Res 91 (2002) 218-225
201. Buselli E.F., and Stuart E.M. Influence of psychosocial factors and biopsychosocial interventions on outcomes after myocardial infarction. J Cardiovasc Nurs 13 (1999) 60-72
202. Marshall D.W., Westmoreland B.F., and Sharbrough F.W. Ictal tachycardia during temporal lobe seizures. Mayo Clin Proc 58 (1983) 443-446
203. Nei M., Ho R.T., Abou-Khalil B.W., et al. EEG and ECG in sudden unexplained death in epilepsy. Epilepsia 45 (2004) 338-445
204. Devinsky O. Effects of seizures on autonomic and cardiovascular function. Epilepsy Curr 4 (2004) 43-46
205. Devinsky O., Barr W.B., Vickrey B.G., et al. Changes in depression and anxiety after resective surgery for epilepsy. Neurology 65 (2005) 1744-1749
206. Devinsky O. Therapy for neurobehavioral disorders in epilepsy. Epilepsia 45 Suppl. 2 (2004) 34-40
207. Altshuler L.L., Devinsky O., Post R.M., and Theodore W. Depression, anxiety, and temporal lobe epilepsy: laterality of focus and symptoms. Arch Neurol 47 (1990) 284-288
208. Cutting S., Lauchheimer A., Barr W., and Devinsky O. Adult-onset idiopathic generalized epilepsy: clinical and behavioral features. Epilepsia 42 (2001) 1395-1398
209. Lear-Kaul K.C., Coughlin L., and Dobersen M.J. Sudden unexpected death in epilepsy: a retrospective study. Am J Forens Med Pathol 26 (2005) 11-17
210. Samuels M.A. 'Voodoo' death revisited: the modern lessons of neurocardiology. Cleve Clin J Med 74 Suppl. 1 (2007) S8-S16
211. Bowker T.J., Wood D.A., Davies M.J., et al. Sudden, unexpected cardiac or unexplained death in England: a national survey. Q J Med 96 (2003) 269-279
212. Davies M.J. The investigation of sudden cardiac death. Histopathology 34 (1999) 93-98
213. Owada M., Aizawa Y., Kurihar K., Tanabe N., Aizaki T., and Izumi T. Risk factors and triggers of sudden death in the working generation: an autopsy proven case-control study. Tohoku J Exp Med 189 (1999) 245-258
214. Munger R.G., and Booton E.A. Bangungut in Manila: sudden and unexplained death in sleep of adult Filipinos. Int J Epidemiol 27 (1998) 677-684
215. Wong M.L., Ong C.N., Tan T.C., et al. Sudden unexplained death syndrome: a review and update. Trop Geogr Med 44 (1992) S1-S19
216. Nava A., Thiene G., Canciani B., et al. Familial occurrence of right ventricular dysplasia: a study involving nine families. J Am Coll Cardiol 12 (1988) 1222-1228
217. Pashkow F.J. Is stress linked to heart disease? The evidence grows stronger. Cleve Clin J Med 66 (1999) 75-77
218. Glassman A.H., and Shapiro P.A. Depression and the course of coronary artery disease. Am J Psychiatry 155 (1998) 4-11
219. Zigelstein R.C. Treatment of depression in patients with coronary artery disease. JAMA 297 (2007) 1878-1879
220. Alphonso N., Anagnostopoulos P.V., Nolke L., et al. Anomalous coronary artery from the wrong sinus of Valsalva: a physiologic repair strategy. Ann Thorac Surg 83 (2007) 1472-1476
221. Beta-Blocker Heart Attack Trial (BHAT). Available at: http://clinicaltrials.gov and www.nhlbi.nih.gov.
222. Bose B.C., Saifi A.Q., and Sharma S. Studies on anticonvulsant and antifibrillatory drugs. Arch Int Pharmacodyn 146 (1963) 106-113
223. Conway J., Greenwood D.T., and Middlemiss D.N. Central nervous actions of β-adrenoceptor antagonists. Clin Sci Mol Med 54 (1978) 119-124
224. Papanicolaou J., Vajda F.J., Summers R.J., and Louis W.J. Role of beta-adrenoceptors in the anticonvulsant effect of propranolol on leptazol-induced convulsions in rats. J Pharm Pharmacol 34 (1982) 124-125
225. Dashputra P.G., Patki V.P., and Hemnani T.J. Antiepileptic action of beta-adrenergic blocking drugs: pronethal and propranolol. Mater Med Pol 2 (1985) 88-92
226. Jaeger V., Esplin B., and Capek R. The anticonvulsant effects of propranolol and beta-adrenergic blockade. Experientia 35 (1979) 8081
227. Murmann W., Almirante L., and Saccani-Gueil M. Central nervous system effects of four beta-adrenergic receptor blocking agents. J Pharm Pharmacol 18 (1966) 317-318
228. Tocco D.J., Clineschmidt B.V., Duncan A.E.W., Deluna F.A., and Baer J.R. Uptake of the beat-adrenergic agents propranolol and timolol by rodent brains: relationship to central pharmacological action. J Cardiovas Res 2 (1980) 425-492
229. Mueller A.L., and Dunwiddie T.V. Anticonvulsant and proconvulsant actions of alpha- and beta-noradrenergic agonists on epileptiform activity in rat hippocampus in vitro. Brain Res 24 (1983) 57-64
230. Louis W.J., Papanicolaou J., Summers R.J., and Vajda F.J.E. Role of central beta adrenoceptors in the control of pentylenetetrazol-induced convulsions in rats. Br J Pharmacol 75 (1982) 441-446
231. Lathers C.M., Jim K., and Spivey W.H. A comparison of intraosseous and intravenous routes of administration of antiseizure agents. Epilepsia 30 (1989) 472-479
232. Spivey W.H., Unger H.D., Lathers C.M., and McNamara R.M. Intraosseous diazepam suppression of pentylenetetrazol-induced epileptogenic activity in pigs. Ann Emerg Med 16 (1987) 156-159
233. Lints C.E., and Nyquist-Battie C. A possible role for beta-adrenergic receptors in the expression of audiogenic seizures. Pharmacol Biochem Behav 22 (1985) 711-716
234. Dailey J.W., and Jobe P.C. Indices of noradrenergic function in the central nervous system of seizure-nai{dotless}̈ve genetically epilepsy-prone rats. Epilepsia 27 (1986) 665-670
235. Mueller A.L., and Dunwidde T.V. Anticonvulsant and proconvulsant actions of alpha- and beta-noradrenergic agonists on epileptiform activity in rat hippocampus in vitro. Epilepsia 24 (1983) 57-64
236. Tackett R.L., Webb J.G., and Privitera P.J. Cerebroventricular propranolol elevates cerebrospinal fluid norepinephrine and lowers blood pressure. Science 213 (1981) 911-913
237. Patil P.N. Steric aspects of adrenergic drugs: 8. Optical isomers of beta adrenergic receptor antagonists. J Pharmacol Exp Ther 160 (1968) 308-314
238. Goldman B.D., Stauffer A.Z., and Lathers C.M. Beta blocking agents and the prevention of sudden unexpected death in the epileptic person: possible mechanisms. Fed Proc 46 (1987) 705
239. Mueller A.L., Palmer M.R., Hoffer B.J., and Dunwiddie T.V. Hippocampal noradrenergic responses in vivo and in vitro: characterization of alpha and beta components. Naunyn Schmiedberg's Arch Pharmacol 318 (1982) 259-266
240. Spivey W.H., Unger H.D., McNamara R.M., LaManna M.M., Ho T., and Lathers C.M. The effect of intraosseous sodium bicarbonate on bone in swine. Ann Emerg Med 16 (1987) 773-776
241. Lathers C.M., Tumer N., and Schoffstall J.M. The effect of different routes of sodium bicarbonate administration on plasma catecholamines, pH, and blood pressure during cardiac arrest in pigs. Resuscitation 18 (1989) 59-74
242. Lathers C.M., Jim K.F., High W., Spivey W.H., Matthews W.D., and Ho T. An investigation of the pathological and physiological effects of intraosseous sodium bicarbonate in pigs. J Clin Pharmacol 29 (1989) 354-359
243. Schoffstall J., Spivey W.H., Davidheiser S., and Lathers C.M. Intraosseous crystalloid and blood infusion in a swine model. J Trauma 27 (1989) 384-387
244. Jim K.F., Lathers C.M., Spivey W.H., Matthews W.D., Kahn C., and Dolce K. Suppression of pentylenetetrazol-elicited seizure activity by intraosseous propranolol in pigs. J Clin Pharmacol 28 (1988) 1106-1111
245. Lathers C.M., Jim K.F., and Spivey W.H. A comparison of intraosseous and intravenous routes of administration for antiseizure agents. Epilepsia 30 (1989) 472-479
246. Jim K.F., Lathers C.M., Farris V.L., Pratt L.F., and Spivey W.H. Suppression of pentylenetetrazol elicited seizure activity by intraosseous lorazepam in pigs. Epilepsia 30 (1989) 480-486
247. McAlister F.A., and Teo K.K. Antiarrhythmic therapies for the prevention of sudden cardiac death. Drugs 54 (1997) 235-252
248. Kochs M., Eggeling T., and Hombach V. Pharmacological therapy in coronary heart disease: prevention of life-threatening ventricular tachyarrhythmias and sudden cardiac death. Eur Heart J 14 Suppl. E (1993) 107-119
249. Merino J.L. Mechanisms underlying ventricular arrhythmias in idiopathic dilated cardiomyopathy: implications for management. Am J Cardiovasc Drugs 1 (2001) 105-118
250. Corrado D., Basso C., Nava A., and Thiene G. Arrhythmogenic right ventricular cardiomyopathy: current diagnostic and management strategies. Cardiol Rev 9 (2001) 259-265
251. Corrado D., Buja G., Basso C., and Thiene G. Clinical diagnosis and management strategies in arrhythmogenic right ventricular cardiomyopathy. J Electrocardiol 33 Suppl. (2000) 49-55
252. Sperling M.R., O'Connor M.J., Saykin A.J., and Plummer C. Temporal lobectomy for refractory epilepsy. JAMA 276 (1996) 470-475
253. So E.L. Demystifying sudden unexplained death in epilepsy: are we close? Epilepsia 47 Suppl. 1 (2006) 87-92
254. Keilson M.J., Hauser W.A., Magrill J.P., and Goldman M. ECG abnormalities in patients with epilepsy. Neurology 37 (1987) 1624-1626
255. Blumhardt L.D., Smith P.E., and Owen L. Electrocardiographic accompaniments of temporal lobe epileptic seizure. Lancet 1 (1986) 1051-1056
256. Van Buren J.M., and Ajmoone-Marsan C. Correlations of autonomic and EEG components in temporal lobe epilepsy. Arch Neurol 3 (1960) 683-703
257. Novak V., Reeves A.L., Novak P., Low P.A., and Sharbrough F.W. Time-frequency mapping of R-R interval during complex partial seizures of temporal lobe origin. J Auton Nerv Syst 24 (1999) 195-202
258. Everengul H., Tanriverdi H., Dursunoglu D., et al. Time frequency domain analyses of heart rate variability in patients with epilepsy. Epilepsy Res 63 (2005) 131-139
259. Goldberger A.L. Fractal mechanisms in the electrophysiology of the heart. IEEE Eng Med Biol Mag 11 (1992) 47-52
260. Goldberger A.L. Is the normal heartbeat chaotic or homeostatic?. New Physiol Sci 6 (1991) 87-91
261. Poon C.S., and Merrill C.K. Decrease of cardiac chaos in congestive heart failure. Nature 389 (1997) 492-495
262. Peng C.K., Havlin S., Stanley H.E., and Goldberger A.L. Quantification of scaling exponents and crossover phenomena in nonstationary heartbeat time series. Chaos 5 (1995) 82-87